SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-030281
Filing Date
2022-09-02
Accepted
2022-09-02 16:10:15
Documents
2
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1649
2 EX-24 DOCUMENT attachment1.htm EX-24 4364
  Complete submission text file 0000899243-22-030281.txt   7324
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2503 SOUTH LOOP DRIVE AMES IA 50010
Business Address
Kennedy Eugene P. (Reporting) CIK: 0001721685 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 221225225